EUVIMEDEUVIMED entdecken
Crossref

Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk scoring

Noushin Fahimfar, Sareh Eghtesad, Hossein Poustchi, Karim Kohansal, Sadaf G Sepanlou, Afshin Ostovar, Ali Esmaeili-Nadimi, Ehsan Bahramali, Farhad Pourfarzi, Samad Ghaffari, Azim Nejatizadeh, Farhad Moradpour und 14 weitere

Journal of Public Health · 2025

DOI: 10.1093/pubmed/fdaf037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Public Health, 2025. Verfasst von Noushin Fahimfar und 25 weiteren Autor:innen. Beteiligte Einrichtung: Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713119, Ir…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Mass Screening. Die Arbeit nennt 38 Literaturangaben. Gefördert von: PERSIAN Cohort.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We compared non-laboratory models’ efficacy with standard laboratory-based model in identifying high-risk populations for cardiovascular disease (CVD) in resource-limited settings.

Methods

A national sample of 121 672 individuals aged 40–70 from the PERSIAN cohort was analyzed. Non-laboratory models, including the World Health Organization (WHO) and Iranian pooled-cohort CVD mortality models, were compared with the WHO laboratory-based model. Intra-class correlation coefficient (ICC) and concordance correlation coefficient (CCC) were utilized. Sensitivity and specificity of non-laboratory models were evaluated against the laboratory-based one at various risk thresholds. The number of reduced tests in the stepwise approach was calculated considering the Iranian census.

Results

Both non-laboratory and laboratory-based models showed similar trends in predicting CVD risks across age groups. Strong correlations and concordance were observed in both men (ICC: 94.4%, CCC:0.893) and women (ICC: 93.8%, CCC:0.883). Utilizing a 5% risk threshold for WHO non-laboratory and 2% for the Iranian pooled-cohort CVD mortality model as the initial step achieved high sensitivity (99.6%) and moderate specificity (52%) for identifying candidates for the second-step laboratory test. This approach effectively reduced the number of tests by 16 807 982.

Conclusion

Non-laboratory models, in a stepwise approach, offer a promising strategy to alleviate strain on financial resources and enhance healthcare system efficiency in resource-limited countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMass ScreeningHumansMiddle AgedFemaleMaleAdultIranAgedRisk AssessmentSensitivity and SpecificityWorld Health OrganizationCohort Studies

Stichwörter der Autor:innen

cardiovascular diseasespredictionpublic healthscreeningsensitivity and specificity

Autor:innen und Institutionen

  • Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713119, Iran.
  • Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, 1417613151, Iran.
  • Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1411713014, Iran.
  • Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, 1985717413, Iran.
  • Digestive Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, 1411713014, Iran.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713119, Iran.

Förderung

  • PERSIAN Cohort

Zitieren

APA

Fahimfar, N., Eghtesad, S., Poustchi, H., Kohansal, K., Sepanlou, S. G., Ostovar, A., Esmaeili-Nadimi, A., Bahramali, E., Pourfarzi, F., Ghaffari, S., Nejatizadeh, A., Moradpour, F., Mousavizadeh, A., Joukar, F., Bitaraf, S., Mohammadkarimi, V., Najafi, F., Hosseini, S. V., Gohari, A., …, & Khalili, D. (2025). Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk scoring. Journal of Public Health. https://doi.org/10.1093/pubmed/fdaf037

Vancouver

Fahimfar N, Eghtesad S, Poustchi H, Kohansal K, Sepanlou SG, Ostovar A, et al. Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk scoring. Journal of Public Health. 2025. doi:10.1093/pubmed/fdaf037

BibTeX
@article{Fahimfar2025,
  author = {Fahimfar, Noushin and Eghtesad, Sareh and Poustchi, Hossein and Kohansal, Karim and Sepanlou, Sadaf G and Ostovar, Afshin and Esmaeili-Nadimi, Ali and Bahramali, Ehsan and Pourfarzi, Farhad and Ghaffari, Samad and Nejatizadeh, Azim and Moradpour, Farhad and Mousavizadeh, Ali and Joukar, Farahnaz and Bitaraf, Saeid and Mohammadkarimi, Vahid and Najafi, Farid and Hosseini, Seyed Vahid and Gohari, Ali and Khaledifar, Arsalan and Kheradmand, Motahareh and Khademvatani, Kamal and Lotfi, Mohammad Hasan and Ansari-Moghaddam, Alireza and Malekzadeh, Reza and Khalili, Davood},
  title = {Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk scoring},
  journal = {Journal of Public Health},
  year = {2025},
  doi = {10.1093/pubmed/fdaf037}
}
Kostenlos starten →